This post is from a suggested group
Anti-VEGF Therapy: A Targeted Approach to Controlling Abnormal Blood Vessel Growth
Anti-VEGF therapy is a medical treatment designed to block the activity of vascular endothelial growth factor (VEGF), a protein responsible for the formation of new blood vessels in the body. While VEGF plays an important role in normal healing and tissue growth, excessive VEGF activity can lead to abnormal blood vessel formation associated with several serious eye conditions and other diseases. Anti-VEGF treatments help control this process and protect vision and tissue health.
What Is Anti-VEGF Therapy?
Anti-VEGF therapy involves the use of medications that inhibit VEGF activity. By blocking this protein, the treatment reduces abnormal blood vessel growth and leakage, particularly in delicate tissues such as the retina. This approach is widely used in ophthalmology and certain oncology settings to manage conditions linked to unwanted vascular development.
Anti-VEGF medications are typically administered through carefully controlled injections or intravenous methods depending on the condition being treated.